
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
' The Food and Drug Administration has granted priority review status to Roche's application for a 500-milligram formulation of its protease inhibitor Invirase. ' Gilead Sciences has announced it will include Truvada, its new nucleoside reverse transcriptase inhibitor, in the company's U.S. patient assistance program. Gilead also will sell the drug, which combines Emtriva and Viread in a single pill, at a no-profit price in developing countries. ' A study by the San Francisco health department has shown that two antiretroviral regimens containing the nonnucleoside reverse transcriptase inhibitor Sustiva provide the highest survival rates out of 39 drug combinations studied. ' Higher doses of the protease inhibitor Kaletra could be beneficial to patients who have failed multiple anti-HIV regimens, according to a study done by researchers in Spain, France, and the United States. ' French researchers have reported that a maintenance regimen containing the anti-HIV drugs Sustiva and Viread, a nucleotide analog, is as effective as a three-drug cocktail in lowering HIV viral loads and boosting CD4-cell counts. ' Genetic tests have shown that after more than five years of treatment with Kaletra, no previously treatment-naive patients developed resistance to the protease inhibitor, U.S. researchers reported in July. ' U.S. researchers reported in July that a study of HIV patients participating in the early access program for the fusion inhibitor Fuzeon has shown that self-administered injections of the drug were well tolerated, including in patients with a history of injection-drug use. ' A study in the July 14 edition of The Journal of the American Medical Association showed that once-daily use of Emtriva, a nucleoside reverse transcriptase inhibitor, had a better virologic response, boosted CD4-cell counts higher, and was better tolerated than twice-daily Zerit. ' A study in the June edition of the journal Antiviral Therapy has shown that switching to a once-daily anti-HIV-drug regimen containing Videx, Viread, and Viramune might lower viral levels but could cause a drop in CD4 cells. ' A study in the July 3 edition of The Lancet indicated that HIV patients taking both Videx and Viread were 11 times more likely to develop pancreatitis than patients taking either drug alone. ' A South African study has shown that blood-based levels of Viramune are doubled in patients also taking the antifungal drug Diflucan, which increases the risk for Viramune-related liver toxicity. ' A study in the July 29 edition of The New England Journal of Medicine has shown the highest efficacy rate ever achieved for treating hepatitis C in HIV-coinfected patients by using both Pegasys (peginterferon) and Ribavirin. A 40% efficacy rate was reported. ' A Brazilian doctor reported in July that five years of follow-up of 441 HIV-positive men and 63 HIV-positive women who received two sessions of injections of a solution containing polymethylmethacrylate, a type of bone cement, to treat facial lipoatrophy, has shown the cosmetic surgical procedure to be safe, effective, and long-lasting. ' Supplements of the amino acid acetyl-L-carnitine have shown the ability to reverse nerve damage in people with antiretroviral-related neuropathy, according to a study in the July 23 edition of the journal AIDS. Increases in nerve numbers were seen in all study patients after six months. ' The blood-lipid'lowering medicationfenofibrate'sold in the United States under the brand names Tricor and Lofibra'has shown the ability to be effective in treating hypertriglyceridemia, a condition associated with antiretrorival therapy, according to a study in the June edition of American Journal of Medical Sciences. ' Researchers from the Washington University School of Medicine reported in the August 1 issue of Clinical Infectious Diseases that extended-release niacin supplements might have the ability to lower blood-based lipid levels in people taking anti-HIV drugs. Total cholesterol levels fell 14%, and triglycerides were reduced 34% in some of the subjects studied. ' A study in the August 15 edition of The Journal of Infectious Diseases recommends against using prednisolone to treat HIV-associated pleural tuberculosis because the drug can boost the risks for developing Kaposi's sarcoma, a form of cancer that is associated with immune system deficiencies. ' Biotechnology company GenVec launched a Phase I clinical trial in July of an experimental HIV vaccine designed to prevent HIV disease progression to an AIDS diagnosis. It targets clades A, B, and C of the virus. ' U.S. researchers reported in July that a short study of an HIV microbicide containing a 1% concentration of Gilead Sciences' antiretroviral compound tenofovir has shown that no significant toxicity symptoms were associated with use of the product. ' Merck granted a license in July to South African generic drug firm Thembalami Pharmaceuticals to produce a generic version of efavirenz, sold in the United States as Sustiva.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Meet ​our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM